Skip to main content
ImmuneCited
Figure 3. Plasma concentration of quercetin and its lecithin-based formulation. This pharmacokinetics study compared two groups of healthy volunteers supplemented with quercetin or quercetin phospholipids. Details are reported in the text. Partly modified
Figure 4. Figure 3. Plasma concentration of quercetin and its lecithin-based formulation. This pharmacokinetics study compared two groups of healthy volunteers supplemented with quercetin or quercetin phospholipids. Details are reported in the text. Partly modified from Ref. [73].

Descrição

Plasma concentration curves comparing standard quercetin and its lecithin-based (phytosomal) formulation, demonstrating enhanced oral bioavailability of the lipid-based delivery system.

Cite This Figure

![Figure 4: Plasma concentration curves comparing standard quercetin and its lecithin-based (phytosomal) formulation, demonstrating enhanced oral bioavailability of the lipid-based delivery system.](https://pdfs.citedhealth.com/figures/40362785/512.png)

> Source: Matteo Naso et al. "Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergi." *Nutrients*, 2025. PMID: [40362785](https://pubmed.ncbi.nlm.nih.gov/40362785/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/40362785/512.png" alt="Plasma concentration curves comparing standard quercetin and its lecithin-based (phytosomal) formulation, demonstrating enhanced oral bioavailability of the lipid-based delivery system." />
  <figcaption>Figure 4. Plasma concentration curves comparing standard quercetin and its lecithin-based (phytosomal) formulation, demonstrating enhanced oral bioavailability of the lipid-based delivery system.<br>  Source: Matteo Naso et al. "Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergi." <em>Nutrients</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40362785/">40362785</a></figcaption>
</figure>